Mehta, Bella
Goodman, Susan
DiCarlo, Edward
Jannat-Khah, Deanna
Gibbons, J. Alex B.
Otero, Miguel
Donlin, Laura
Pannellini, Tania
Robinson, William H.
Sculco, Peter
Figgie, Mark
Rodriguez, Jose
Kirschmann, Jessica M.
Thompson, James
Slater, David
Frezza, Damon
Xu, Zhenxing
Wang, Fei
Orange, Dana E.
Article History
Received: 17 November 2022
Accepted: 6 February 2023
First Online: 2 March 2023
Declarations
:
: Ethical approval for this study was provided by the Institutional Review Board at the Hospital for Special Surgery (IRB #2018-0895 and #2014-233), and the research was performed in accordance with the relevant guidelines and regulations.
: Bella Mehta, MBBS, MS: Novartis Non-labeled educational content development; Janssen Advisory board. Susan M. Goodman, MD: American College of Rheumatology Board or committee member, Novartis Research support, UCB Paid consultant. Deanna P. Jannat-Khah, DrPH, MSPH: AstraZeneca, Cytodyn, Walgreens stocks. Miguel Otero, PhD: Regeneron Pharmaceuticals paid consultant; Tissue Genesis Research support. Laura Donlin, PhD: Karius, Inc Research support. Stryker Paid consultant and paid speaker. Mark P. Figgie, MD: Lima and Wishbone paid consultant; HS2, Mekanika, and Wishbone stocks. Jose A. Rodriguez, MD: Board or committee member for the American Association of Hip and Knee Surgeons and the Eastern Orthopaedic Association Nomination Committee. Paid consultant and received IP royalties from ConforMIS, Medacta, Exactech, Inc, and Smith & Nephew. Research support from DePuy, Exactech, Inc, and Smith & Nephew. Editorial or governing board of <i>Clinical Orthopaedics and Related Research</i>, <i>HSS Journal</i>, and <i>Journal of Arthroplasty</i>.